Page last updated: 2024-08-17

medroxyprogesterone acetate and Biliary Cirrhosis

medroxyprogesterone acetate has been researched along with Biliary Cirrhosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kahan, BC; Morris, TP	1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Biliary Cirrhosis

Article	Year
Improper analysis of trials randomised using stratified blocks or minimisation. Statistics in medicine, 2012, Feb-20, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Back Injuries; Bias; Breast Neoplasms; Carcinoma; Computer Simulation; Data Interpretation, Statistical; Deoxyribonucleases; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Interferon-alpha; Kidney Neoplasms; Liver Cirrhosis, Biliary; Male; Medroxyprogesterone Acetate; Penicillamine; Pleural Effusion; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Tissue Plasminogen Activator; Treatment Outcome	2012

Article

Year

Improper analysis of trials randomised using stratified blocks or minimisation.

Statistics in medicine, 2012, Feb-20, Volume: 31, Issue:4

Topics: Antineoplastic Agents; Back Injuries; Bias; Breast Neoplasms; Carcinoma; Computer Simulation; Data Interpretation, Statistical; Deoxyribonucleases; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Interferon-alpha; Kidney Neoplasms; Liver Cirrhosis, Biliary; Male; Medroxyprogesterone Acetate; Penicillamine; Pleural Effusion; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Tissue Plasminogen Activator; Treatment Outcome

2012